CRISPR Therapeutics AG - CRSP - stock price prediction, stock price target, analyst ratings from 28 analysts

CRISPR Therapeutics AG has a share price target of US$ 81, revenue growth forecast of -83.3%, and profit growth estimate of -49.6% for FY25, based on top 28 analyst calls.